Ocular Therapeutix, Inc. (OCUL)
10.38
-0.24
(-2.26%)
USD |
NASDAQ |
Sep 11, 15:43
Ocular Therapeutix Gross Profit (TTM) : 45.35M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.35M |
| March 31, 2026 | 45.40M |
| December 31, 2025 | 45.38M |
| September 30, 2025 | 49.57M |
| June 30, 2025 | 50.67M |
| March 31, 2025 | 54.08M |
| December 31, 2024 | 58.10M |
| September 30, 2024 | 55.66M |
| June 30, 2024 | 55.50M |
| March 31, 2024 | 54.45M |
| December 31, 2023 | 53.16M |
| September 30, 2023 | 52.81M |
| June 30, 2023 | 50.00M |
| March 31, 2023 | 47.23M |
| December 31, 2022 | 46.95M |
| September 30, 2022 | 45.09M |
| June 30, 2022 | 45.04M |
| March 31, 2022 | 44.55M |
| December 31, 2021 | 39.12M |
| September 30, 2021 | 34.58M |
| June 30, 2021 | 28.50M |
| March 31, 2021 | 18.61M |
| December 31, 2020 | 13.95M |
| September 30, 2020 | 8.359M |
| June 30, 2020 | 3.621M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.25M |
| December 31, 2019 | 0.048M |
| September 30, 2019 | -1.227M |
| June 30, 2019 | -1.44M |
| March 31, 2019 | -0.868M |
| December 31, 2018 | -0.761M |
| September 30, 2018 | -0.72M |
| June 30, 2018 | -0.614M |
| March 31, 2018 | -0.563M |
| December 31, 2017 | -0.159M |
| September 30, 2017 | 0.2525M |
| June 30, 2017 | 0.5935M |
| March 31, 2017 | 0.7425M |
| December 31, 2016 | 0.8658M |
| September 30, 2016 | 0.7523M |
| June 30, 2016 | 0.704M |
| March 31, 2016 | 0.767M |
| December 31, 2015 | 0.7417M |
| September 30, 2015 | 0.9087M |
| June 30, 2015 | 0.811M |
| March 31, 2015 | 0.545M |
| December 31, 2014 | 0.273M |
| September 30, 2014 | -0.132M |
| June 30, 2014 | -0.336M |
| March 31, 2014 | -0.262M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| EyePoint, Inc. | -0.51M |
| Merck & Co., Inc. | 48.01B |
| Theravance Biopharma, Inc. | 98.52M |
| LENZ Therapeutics, Inc. | 19.36M |
| ANI Pharmaceuticals, Inc. | 505.18M |